Stay updated on Epacadostat and Pembrolizumab in Advanced Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Epacadostat and Pembrolizumab in Advanced Pancreatic Cancer Clinical Trial page.

Latest updates to the Epacadostat and Pembrolizumab in Advanced Pancreatic Cancer Clinical Trial page
- CheckyesterdayChange DetectedAdded Revision: v3.3.4 and removed Revision: v3.3.3, indicating a version update of the page. No study details or user-facing functionality are altered.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedRevision: v3.3.3 is now displayed; HHS Vulnerability Disclosure and Revision: v3.3.2 have been removed.SummaryDifference0.1%

- Check44 days agoChange DetectedRevision history updated to add v3.3.2 and remove v3.3.1. These are administrative metadata changes that do not modify study content.SummaryDifference0.1%

- Check51 days agoChange DetectedAdded Revision: v3.3.1; Deleted Revision: v3.2.0.SummaryDifference0.1%

- Check59 days agoChange DetectedThe notice about a lapse in government funding has been removed from the Study Details page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check73 days agoChange DetectedThe page now shows the study Withdrawn with sponsor support ended. This indicates the trial is no longer active and enrollment is unlikely to proceed.SummaryDifference0.4%

Stay in the know with updates to Epacadostat and Pembrolizumab in Advanced Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Epacadostat and Pembrolizumab in Advanced Pancreatic Cancer Clinical Trial page.